跳至主要内容
临床试验/IRCT2016120528967N3
IRCT2016120528967N3已完成2 期

Comparative investigate the effect of vitexagnus _castus(agnugol) and Placebo on menopausal symptoms: a double-blind randomized clinical trial

Vice chancellor for research, Kermanshah University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 65 years(—)
性别
Female

入选标准

  • •age between 65-45 years; at least one year and a maximum of three years of their last menstrual period has passed; the number of hot flashes at least 2 times a day. Exclusion criteria: smoking; at least for a period of 3 months are treated with hormones and antibiotics; systemic diseases such as kidney disease; blood pressure blood sugar; blood fat; depressed and anxious (anxiety and depression diagnosis based on diagnostic criteria DSM5 by psychiatrist); taking antithyroid drugs; gabapentin; SSRI; sulfonamides, methotrexate, Tryamtryn, sulfasalazine; the use of traditional medicines such as drug-induced flushing.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Kermanshah University of Medical Sciences

相似试验

Compareing effects ofvitexagnus _castus(agnugol) and... | 临床试验